Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00122642

Alcohol Locks for the Prevention of Tunneled Catheter-related Infections

Short Daily Alcohol Locks for the Prevention of Tunneled Catheter Infection in Patients With Haematological Disease. Randomised Placebo Controlled Trial

Sponsor: Erasmus Medical Center

Conditions Bacteremia

Interventions Alcohol-lock placebo-lock

Updated 6 times since 2017 Last updated: Sep 24, 2009 Started: Aug 31, 2005 Primary completion: Jun 30, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00122642, this PHASE2/PHASE3 trial focuses on Bacteremia and remains completed. Sponsored by Erasmus Medical Center, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erasmus Medical Center
Stichting Nuts Ohra

Data source: Erasmus Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rotterdam, Netherlands